PU.1 is not strictly required for B cell development and its absence induces a B-2 to B-1 cell switch

被引:69
作者
Ye, M [1 ]
Ermakova, O [1 ]
Graf, T [1 ]
机构
[1] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA
关键词
D O I
10.1084/jem.20051089
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In this paper, we describe the unexpected outgrowth of B lineage cells from PU.1(-/-) fetal liver cultures. The cells express all early B cell genes tested, including the putative PU.1 target genes IL-7R and EBF but not B220, and can produce immunoglobulin M. However, we observed a delay in the PU.1(-/-) B cell outgrowth and reduced precursor frequencies, indicating that although PU.1 is not strictly required for B cell commitment, it facilitates B cell development. We also ablated PU.1 in CD19-expressing B lineage cells in vivo, using a Cre-lox approach that allows them to be tracked. PU.1 excision resulted in a shift from B-2 cells to B-1-like cells, which dramatically increased with the age of the mice. Our data indicate that this shift is predominantly caused by a B-2 to B-1 cell reprogramming. Furthermore, we found that B-2 cells express substantially more PU.1 than B-1 cells, which is consistent with the idea that maintenance of the B-2 cell phenotype requires relatively high levels of PU.1, but B-1 cells require little.
引用
收藏
页码:1411 / 1422
页数:12
相关论文
共 36 条
[1]   PU.1 is a lineage-specific regulator of tyrosine phosphatase CD45 [J].
Anderson, KL ;
Nelson, SL ;
Perkin, HB ;
Smith, KA ;
Klemsz, MJ ;
Torbett, BE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (10) :7637-7642
[2]   Origins and functions of B-1 cells with notes on the role of CD5 [J].
Berland, R ;
Wortis, HH .
ANNUAL REVIEW OF IMMUNOLOGY, 2002, 20 :253-300
[3]   TcR-α/β+ CD4-CD8- T cells in humans with the autoimmune lymphoproliferative syndrome express a novel CD45 isoform that is analogous to murine B220 and represents a marker of altered O-glycan biosynthesis [J].
Bleesing, JJH ;
Brown, MR ;
Dale, JK ;
Straus, SE ;
Lenardo, MJ ;
Puck, JM ;
Atkinson, TP ;
Fleisher, TA .
CLINICAL IMMUNOLOGY, 2001, 100 (03) :314-324
[4]   The follicular versus marginal zone B lymphocyte cell fate decision is regulated by Aiolos, Btk, and CD21 [J].
Cariappa, A ;
Tang, M ;
Parng, C ;
Nebelitskiy, E ;
Carroll, M ;
Georgopoulos, K ;
Pillai, S .
IMMUNITY, 2001, 14 (05) :603-615
[5]   B cell receptor signal strength determines B cell fate [J].
Casola, S ;
Otipoby, KL ;
Alimzhanov, M ;
Humme, S ;
Uyttersprot, N ;
Kutok, JL ;
Carroll, MC ;
Rajewsky, K .
NATURE IMMUNOLOGY, 2004, 5 (03) :317-327
[6]   Mechanisms of disease: Chronic lymphocytic leukemia [J].
Chiorazzi, N ;
Rai, KR ;
Ferrarini, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (08) :804-815
[7]   PU.1 regulates the commitment of adult hematopoietic progenitors and restricts granulopoiesis [J].
Dakic, A ;
Metcalf, D ;
Di Rago, L ;
Mifsud, S ;
Wu, L ;
Nutt, SL .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (09) :1487-1502
[8]   Regulation of BCR signal transduction in B-1 cells requires the expression of the Src family kinase Lck [J].
Dal Porto, JM ;
Burke, K ;
Cambier, JC .
IMMUNITY, 2004, 21 (03) :443-453
[9]   PU.1 regulates expression of the interleukin-7 receptor in lymphoid progenitors [J].
DeKoter, RP ;
Lee, HJ ;
Singh, H .
IMMUNITY, 2002, 16 (02) :297-309
[10]   PU.1 regulates both cytokine-dependent proliferation and differentiation of granulocyte/macrophage progenitors [J].
DeKoter, RP ;
Walsh, JC ;
Singh, H .
EMBO JOURNAL, 1998, 17 (15) :4456-4468